Developer docs
API playgroundTry for free, no card

Search company profiles

Hydrocision

Full company profile

uuid0002wm8

Namestring
Hydrocision
Legal namestring
HydroCision, Inc.
Websiteurl
hydrocision.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

HydroCision is a privately held medical device company founded in 1994 and headquartered in North Billerica, Massachusetts, that develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine and orthopedic procedures. The company's proprietary FluidJet technology delivers a high-velocity stream of sterile saline that simultaneously cuts and aspirates tissue via a Venturi suction effect, operating non-thermally to avoid collateral tissue damage and enabling selective resection of pathologic tissue while sparing healthy structures. Its commercial portfolio comprises three products built on a shared power console platform: TenJet for chronic tendinopathy and tenotomy procedures, SpineJet for percutaneous discectomy in contained lumbar disc herniations, and AlloJet for bone allograft preparation in tissue banks. The company also licenses its core pump cartridge and fluid-jet technology to third parties, including an exclusive worldwide urology license to PROCEPT BioRobotics (Aquablation therapy for BPH, used in PROCEPT's 2021 IPO) and an exclusive wound-care license to Smith & Nephew, generating upfront payments and ongoing royalties.

The business operates a sales-led, direct sales model with dedicated sales representatives for each product line, targeting orthopedic surgeons, sports medicine physicians, podiatrists, pain management specialists, and tissue banks across the United States, supported by a sales portal, physician finder tool, and clinical education programs (TenJet Sports Medicine Physicians Group, monthly webinars). Revenue is generated through hardware sales of consoles and recurring single-use handpieces, procedure reimbursement from Medicare and private insurers, and technology licensing royalties. The company employs 11-50 people, is backed by investors including Volcano Capital, BioVentures Investors, and Omega Funds, and has been led since 2019 by a series of commercial-experienced CEOs (most recently Rick Lytle, formerly of Covidien and ArjoHuntleigh). HydroCision's IP moat rests on a patent estate including US Patent 11,278,305 covering selective tendon tissue removal, and FDA clearances across multiple clinical applications.

Short descriptiontext

HydroCision develops and markets proprietary FluidJet-based minimally invasive surgical devices—TenJet for tendinopathy, SpineJet for discectomy, and AlloJet for allograft preparation—selling directly to orthopedic surgeons, spine specialists, and tissue banks while licensing its core technology to partners like PROCEPT BioRobotics and Smith & Nephew.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBillerica, United States
HQ citystring
Billerica
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
minimally invasive surgery, fluid jet medical devices, tendon tenotomy devices, percutaneous discectomy tools, allograft debridement systems
Industry3 codes
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAK
Suction, Irrigation & Fluid Management Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Minimally Invasive Surgical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

HydroCision generates revenue through the sale of its proprietary medical devices including the Series-82 and Series-52 consoles, single-use handpieces (TenJet, SpineJet, AlloJet), and accessories. The company sells directly to healthcare providers and hospitals.

hydrocision.com
2Technology Licensing
TypeLicensing Royalties
Description

HydroCision licenses its FluidJet technology to other medical device companies. Notable licenses include exclusive worldwide license to PROCEPT BioRobotics for urology applications and to Smith & Nephew for wound care applications. Receives upfront payments and ongoing royalties from licensees.

hydrocision.com
3Procedure Reimbursement
TypeTransaction Fee
Description

The tenotomy procedure using TenJet is reimbursed by Medicare and most private insurers. SpineJet HydroDiscectomy procedures are also covered by insurance, varying by insurer and plan.

hydrocision.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Insurance Reimbursement
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

The tenotomy procedure is reimbursed by Medicare and most private insurers. SpineJet HydroDiscectomy insurance coverage varies by insurer and plan. Third-party finance options may be available through physician offices.

hydrocision.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1TenJet
Description

Minimally invasive tenotomy device for treatment of chronic tendinopathy and tendon pain using high-velocity saline jet technology.

hydrocision.com
+3 more records
Core offering1 text field

HydroCision develops, manufactures, and markets minimally invasive surgical devices powered by its proprietary FluidJet technology — a high-velocity, non-thermal sterile saline stream that simultaneously cuts and aspirates targeted tissue. Its commercial product lines include the TenJet tenotomy device for chronic tendon conditions, the SpineJet PercResector for percutaneous discectomy, and the AlloJet allograft debridement system for tissue banks, sold primarily to hospitals and specialists in the United States. The company also licenses its core fluid-jet technology to partners in urology and wound care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 94% improvement in back and leg pain for patients receiving HydroDiscectomy procedure (multi-center study, 50 patients)
+4 more records
Product overview1 text field

HydroCision is a medical device company offering a portfolio of FluidJet technology-based surgical devices. The core platform consists of high-velocity water jet technology that uses pressurized saline for tissue resection without thermal damage. Three main commercial products serve distinct clinical applications: TenJet for orthopedic/tendon treatments in sports medicine, SpineJet for spinal discectomy procedures, and AlloJet for bone allograft tissue preparation. Each product uses customized single-use handpieces designed for specific clinical applications while sharing the common FluidJet power console technology.

Product and service4 records
1TenJet Tenotomy Device
CategorySurgical instruments — orthopedic sports medicine
Description

Minimally invasive tenotomy device using high-velocity saline jet technology to selectively resect and remove diseased tendon tissue while sparing healthy tissue. Treats chronic tendinosis, calcific tendinitis, tennis elbow, golfer's elbow, Achilles tendinosis, plantar fasciitis, and other tendon conditions for orthopedic and sports medicine physicians.

2SpineJet PercResector
CategorySurgical instruments — spine surgery
Description

Percutaneous decompression device using a non-thermal fluid-jet system for treating contained lumbar disc herniations. The 4.0 mm cannulated access set creates a minimally invasive pathway through Kambin's triangle for disc tissue removal in discectomy procedures performed by neurosurgeons, orthopedic spine surgeons, and pain management specialists.

3AlloJet Allograft Debridement System
CategorySurgical instruments — tissue processing
Description

Bone allograft preparation device using a 500 mph high-velocity fluidjet to safely and effectively remove soft tissue from donor bones. Enables sterile cleaning of bone allografts with increased yield and reduced workplace injuries, sold to musculoskeletal tissue banks and tissue processing facilities.

4Series-82 and Series-52 FluidJet Power Consoles
CategorySurgical capital equipment
Description

Capital equipment component of the FluidJet platform. Power consoles deliver pressurized sterile saline at adjustable settings through high-pressure tubing into single-use handpieces (TenJet, SpineJet, AlloJet), generating the high-velocity non-thermal cutting jet that resects and aspirates targeted tissue in a single action.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2019-03-26
Description

HydroCision granted PROCEPT BioRobotics an exclusive worldwide license of its pump cartridge technology for use in urology. PROCEPT uses this technology with their AquaBeam Robotic System for Aquablation therapy - the first surgical robot providing autonomous tissue removal for BPH treatment. PROCEPT subsequently completed an IPO in November 2021.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

HydroCision previously granted Smith & Nephew an exclusive license for use of FluidJet technology in the field of wound care. This was HydroCision's first Field-of-Use License for its technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant privately held sports medicine and orthopedic device company with broad MIS tenotomy, tendon repair, and arthroscopy portfolios. Competes directly with HydroCision's TenJet in treating chronic tendinopathy and overlaps on percutaneous spine access tools.

TypeBroad incumbent
Description

Global medtech incumbent with sports medicine, orthopedics, and advanced wound management franchises. Already a HydroCision licensee for wound care, S&N is also a competitor in MIS sports medicine tenotomy and competes across procedural categories.

TypeBroad incumbent
Description

Large diversified medical device company with deep spine, orthopedics, and sports medicine portfolios. Competes with HydroCision's SpineJet in MIS discectomy and adjacent tendon and sports medicine procedures through its endoscopy and spine divisions.

TypeBroad incumbent
Description

Largest medical device company with a dominant spine surgery franchise (legacy Kyphon/including Covidien). HydroCision CEO and executives came from Covidien/Medtronic, and Medtronic's MIS discectomy and ablation tools compete with SpineJet.

5Tenex Health (Tenex procedure)
TypeDirect peer
Description

Direct competitor to HydroCision's TenJet in ultrasound-guided percutaneous tenotomy for chronic tendinopathy (tennis elbow, Achilles, plantar fasciitis). Targets the same orthopedic and sports medicine specialists with a similar minimally invasive outpatient procedure.

TypeBroad incumbent
Description

Major medical technology company with spine surgery and minimally invasive procedural products. Competes with HydroCision's SpineJet in discectomy and percutaneous access tools, and employs HydroCision alumni (Paul Kowalski) in its commercial ranks.

TypeEmerging player
Description

Public surgical robotics company (NASDAQ: PRCT) commercializing Aquablation therapy for BPH using HydroCision-licensed FluidJet pump cartridge technology. Direct licensee and strategic commercial partner validating the FluidJet platform in urology.

TypeDirect peer
Description

Specialist in minimally invasive spine surgery technologies, including percutaneous discectomy and tissue modulation tools. Directly competes with HydroCision's SpineJet in treating contained disc herniations and MIS decompression.

TypeBroad incumbent
Description

Diversified medical device company with tissue technologies, orthopedics, and neurosurgery franchises. Overlaps with HydroCision in tissue processing (AlloJet) and sports medicine/extremities categories.

10HistoSonics
TypeEmerging player
Description

Emerging non-invasive tissue ablation company using histotripsy (focused ultrasound) — an alternative non-thermal tissue destruction modality that could compete with HydroCision's non-thermal FluidJet in select indications over time.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hydrocision

Minimally Invasive Surgical Deviceshydrocision.com

HydroCision develops and markets proprietary FluidJet-based minimally invasive surgical devices—TenJet for tendinopathy, SpineJet for discectomy, and AlloJet for allograft preparation—selling directly to orthopedic surgeons, spine specialists, and tissue banks while licensing its core technology to partners like PROCEPT BioRobotics and Smith & Nephew.

What Hydrocision does

HydroCision is a privately held medical device company founded in 1994 and headquartered in North Billerica, Massachusetts, that develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine and orthopedic procedures. The company's proprietary FluidJet technology delivers a high-velocity stream of sterile saline that simultaneously cuts and aspirates tissue via a Venturi suction effect, operating non-thermally to avoid collateral tissue damage and enabling selective resection of pathologic tissue while sparing healthy structures. Its commercial portfolio comprises three products built on a shared power console platform: TenJet for chronic tendinopathy and tenotomy procedures, SpineJet for percutaneous discectomy in contained lumbar disc herniations, and AlloJet for bone allograft preparation in tissue banks. The company also licenses its core pump cartridge and fluid-jet technology to third parties, including an exclusive worldwide urology license to PROCEPT BioRobotics (Aquablation therapy for BPH, used in PROCEPT's 2021 IPO) and an exclusive wound-care license to Smith & Nephew, generating upfront payments and ongoing royalties.

The business operates a sales-led, direct sales model with dedicated sales representatives for each product line, targeting orthopedic surgeons, sports medicine physicians, podiatrists, pain management specialists, and tissue banks across the United States, supported by a sales portal, physician finder tool, and clinical education programs (TenJet Sports Medicine Physicians Group, monthly webinars). Revenue is generated through hardware sales of consoles and recurring single-use handpieces, procedure reimbursement from Medicare and private insurers, and technology licensing royalties. The company employs 11-50 people, is backed by investors including Volcano Capital, BioVentures Investors, and Omega Funds, and has been led since 2019 by a series of commercial-experienced CEOs (most recently Rick Lytle, formerly of Covidien and ArjoHuntleigh). HydroCision's IP moat rests on a patent estate including US Patent 11,278,305 covering selective tendon tissue removal, and FDA clearances across multiple clinical applications.

Hydrocision firmographics

Firmographics
Name
Hydrocision
Legal name
HydroCision, Inc.
Website
https://hydrocision.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
HydroCision develops and markets proprietary FluidJet-based minimally invasive surgical devices—TenJet for tendinopathy, SpineJet for discectomy, and AlloJet for allograft preparation—selling directly to orthopedic surgeons, spine specialists, and tissue banks while licensing its core technology to partners like PROCEPT BioRobotics and Smith & Nephew.
Ownership category
akta.pro rank

Hydrocision industry classification

Industry
Product category
Minimally Invasive Surgical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAK
Suction, Irrigation & Fluid Management Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Minimally invasive surgery
  • Fluid jet medical devices
  • Tendon tenotomy devices
  • Percutaneous discectomy tools
  • Allograft debridement systems

Where Hydrocision is headquartered

Location

Headquarters

HQ city
Billerica
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hydrocision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: HydroCision generates revenue through the sale of its proprietary medical devices including the Series-82 and Series-52 consoles, single-use handpieces (TenJet, SpineJet, AlloJet), and accessories. The company sells directly to healthcare providers and hospitals.
  2. Technology Licensing: HydroCision licenses its FluidJet technology to other medical device companies. Notable licenses include exclusive worldwide license to PROCEPT BioRobotics for urology applications and to Smith & Nephew for wound care applications. Receives upfront payments and ongoing royalties from licensees.
  3. Procedure Reimbursement: The tenotomy procedure using TenJet is reimbursed by Medicare and most private insurers. SpineJet HydroDiscectomy procedures are also covered by insurance, varying by insurer and plan.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goInsurance Reimbursement

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Hydrocision product offering

Product offering

Core offering

HydroCision develops, manufactures, and markets minimally invasive surgical devices powered by its proprietary FluidJet technology — a high-velocity, non-thermal sterile saline stream that simultaneously cuts and aspirates targeted tissue. Its commercial product lines include the TenJet tenotomy device for chronic tendon conditions, the SpineJet PercResector for percutaneous discectomy, and the AlloJet allograft debridement system for tissue banks, sold primarily to hospitals and specialists in the United States. The company also licenses its core fluid-jet technology to partners in urology and wound care.

Product overview

HydroCision is a medical device company offering a portfolio of FluidJet technology-based surgical devices. The core platform consists of high-velocity water jet technology that uses pressurized saline for tissue resection without thermal damage. Three main commercial products serve distinct clinical applications: TenJet for orthopedic/tendon treatments in sports medicine, SpineJet for spinal discectomy procedures, and AlloJet for bone allograft tissue preparation. Each product uses customized single-use handpieces designed for specific clinical applications while sharing the common FluidJet power console technology.

Differentiator

Problem solved

Functional benefit

Brands

  • TenJet: Minimally invasive tenotomy device for treatment of chronic tendinopathy and tendon pain using high-velocity saline jet technology.
  • SpineJet
  • AlloJet
  • FluidJet

Products and services

  • TenJet Tenotomy Device Minimally invasive tenotomy device using high-velocity saline jet technology to selectively resect and remove diseased tendon tissue while sparing healthy tissue. Treats chronic tendinosis, calcific tendinitis, tennis elbow, golfer's elbow, Achilles tendinosis, plantar fasciitis, and other tendon conditions for orthopedic and sports medicine physicians.
  • SpineJet PercResector Percutaneous decompression device using a non-thermal fluid-jet system for treating contained lumbar disc herniations. The 4.0 mm cannulated access set creates a minimally invasive pathway through Kambin's triangle for disc tissue removal in discectomy procedures performed by neurosurgeons, orthopedic spine surgeons, and pain management specialists.
  • AlloJet Allograft Debridement System Bone allograft preparation device using a 500 mph high-velocity fluidjet to safely and effectively remove soft tissue from donor bones. Enables sterile cleaning of bone allografts with increased yield and reduced workplace injuries, sold to musculoskeletal tissue banks and tissue processing facilities.
  • Series-82 and Series-52 FluidJet Power Consoles Capital equipment component of the FluidJet platform. Power consoles deliver pressurized sterile saline at adjustable settings through high-pressure tubing into single-use handpieces (TenJet, SpineJet, AlloJet), generating the high-velocity non-thermal cutting jet that resects and aspirates targeted tissue in a single action.

Quantifiable outcome

  • 94% improvement in back and leg pain for patients receiving HydroDiscectomy procedure (multi-center study, 50 patients)
  • +4 more outcomes

Companies that use Hydrocision

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Hydrocision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Hydrocision partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • PROCEPT BioRoboticscoreOEM/ Whitelabel/ Licensing Partner · 26 March 2019HydroCision granted PROCEPT BioRobotics an exclusive worldwide license of its pump cartridge technology for use in urology. PROCEPT uses this technology with their AquaBeam Robotic System for Aquablation therapy - the first surgical robot providing autonomous tissue removal for BPH treatment. PROCEPT subsequently completed an IPO in November 2021.
  • Smith & NephewcoreOEM/ Whitelabel/ Licensing PartnerHydroCision previously granted Smith & Nephew an exclusive license for use of FluidJet technology in the field of wound care. This was HydroCision's first Field-of-Use License for its technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Hydrocision competitors and assessment

Company assessment

Broad incumbents

  • Arthrex: Dominant privately held sports medicine and orthopedic device company with broad MIS tenotomy, tendon repair, and arthroscopy portfolios. Competes directly with HydroCision's TenJet in treating chronic tendinopathy and overlaps on percutaneous spine access tools.
  • Smith & Nephew: Global medtech incumbent with sports medicine, orthopedics, and advanced wound management franchises. Already a HydroCision licensee for wound care, S&N is also a competitor in MIS sports medicine tenotomy and competes across procedural categories.
  • Stryker: Large diversified medical device company with deep spine, orthopedics, and sports medicine portfolios. Competes with HydroCision's SpineJet in MIS discectomy and adjacent tendon and sports medicine procedures through its endoscopy and spine divisions.
  • Medtronic: Largest medical device company with a dominant spine surgery franchise (legacy Kyphon/including Covidien). HydroCision CEO and executives came from Covidien/Medtronic, and Medtronic's MIS discectomy and ablation tools compete with SpineJet.
  • Becton Dickinson (BD): Major medical technology company with spine surgery and minimally invasive procedural products. Competes with HydroCision's SpineJet in discectomy and percutaneous access tools, and employs HydroCision alumni (Paul Kowalski) in its commercial ranks.
  • Integra LifeSciences: Diversified medical device company with tissue technologies, orthopedics, and neurosurgery franchises. Overlaps with HydroCision in tissue processing (AlloJet) and sports medicine/extremities categories.

Direct peers

  • Tenex Health (Tenex procedure): Direct competitor to HydroCision's TenJet in ultrasound-guided percutaneous tenotomy for chronic tendinopathy (tennis elbow, Achilles, plantar fasciitis). Targets the same orthopedic and sports medicine specialists with a similar minimally invasive outpatient procedure.
  • Elliquence: Specialist in minimally invasive spine surgery technologies, including percutaneous discectomy and tissue modulation tools. Directly competes with HydroCision's SpineJet in treating contained disc herniations and MIS decompression.

Emerging players

  • PROCEPT BioRobotics: Public surgical robotics company (NASDAQ: PRCT) commercializing Aquablation therapy for BPH using HydroCision-licensed FluidJet pump cartridge technology. Direct licensee and strategic commercial partner validating the FluidJet platform in urology.
  • HistoSonics: Emerging non-invasive tissue ablation company using histotripsy (focused ultrasound) — an alternative non-thermal tissue destruction modality that could compete with HydroCision's non-thermal FluidJet in select indications over time.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Hydrocision social profiles

Digital presence

Hydrocision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hydrocision leadership team

Management profile

Number of profiles

Profiles7 records

Hydrocision funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hydrocision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hydrocision

What does Hydrocision do?

HydroCision develops, manufactures, and markets minimally invasive surgical devices powered by its proprietary FluidJet technology — a high-velocity, non-thermal sterile saline stream that simultaneously cuts and aspirates targeted tissue. Its commercial product lines include the TenJet tenotomy device for chronic tendon conditions, the SpineJet PercResector for percutaneous discectomy, and the AlloJet allograft debridement system for tissue banks, sold primarily to hospitals and specialists in the United States. The company also licenses its core fluid-jet technology to partners in urology and wound care.

Is Hydrocision a public or private company?

Hydrocision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hydrocision founded?

Hydrocision was founded in 1994. It employs 11 to 50 people.

Where is Hydrocision based?

Hydrocision is headquartered in Billerica, United States, in the North America region.

How does Hydrocision make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are technology Licensing and procedure Reimbursement.

Who are Hydrocision's main competitors?

Broad incumbents on record are Arthrex, Smith & Nephew, Stryker, Medtronic, Becton Dickinson (BD) and Integra LifeSciences. Direct peers are Tenex Health (Tenex procedure) and Elliquence. Emerging players are PROCEPT BioRobotics and HistoSonics.

Does Hydrocision have an API?

No public API is recorded for Hydrocision.

What industry is Hydrocision in?

Hydrocision's product category is Minimally Invasive Surgical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFirst-of-Its-Kind Selective Tissue Removal Patent GrantHydroCision Inc. announced that the U.S. Patent and Trademark Office issued Patent No. 11,278,305 titled "Selective Tissue Removal Treatment Device" for their TenJet device. The TenJet device, utilizing HydroCision's FluidJet technology with pressurized saline, is designed for targeted, selective removal of pathologic tendon tissue while preserving adjacent healthy tissue, with procedures performed under real-time ultrasound guidance in outpatient settings. The CEO noted that patients suffering from chronic tendon pain, after years of failed treatments, can now potentially return to normal life with this minimally invasive approach.PR NewswireHydroCision® Announces Global Licensing Agreement with PROCEPT BioRobotics, Providing Access to its Proprietary Pump Cartridge TechnologyHydroCision, a privately held medical device company specializing in high velocity water jet technology, has granted an exclusive worldwide license of its pump cartridge technology to PROCEPT BioRobotics for use in urology. Under the agreement, PROCEPT BioRobotics will use HydroCision's pumping technology with its AquaBeam Robotic System, which provides autonomous tissue removal for treating Benign Prostatic Hyperplasia (BPH), and HydroCision will receive a one-time upfront payment with confidential terms. This marks HydroCision's second Field-of-Use License, following a previous exclusive license granted to Smith & Nephew for wound care applications.PR NewswireHydroCision® Appoints Medical Device Executive with Global Commercial and Market Development Experience as New CEOHydroCision, a privately held medical device company specializing in high velocity water jet technology for minimally invasive medical procedures, announced the appointment of Alain Tranchemontagne as its new Chief Executive Officer. Tranchemontagne brings extensive commercial and P&L experience from his previous roles at Smith & Nephew and Covidien (Medtronic), having spent eleven years at Smith & Nephew in various senior leadership positions. The appointment marks a leadership transition as the company seeks to accelerate its growth trajectory and expand its patented fluid-jet technology into new surgical applications.